[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting]

Rev Med Interne. 2006 Apr;27(4):330-2. doi: 10.1016/j.revmed.2005.12.004. Epub 2006 Jan 6.
[Article in French]

Abstract

Introduction: HIV infection is the main cause of cryptococcal neuromeningitis but other diseases may be associated with this infection.

Case report: We report a case of cryptococcal neuromeningitis in a patient with sarcoidosis and ventriculoatrial shunting. The patient was successfully treated by effective therapy without device withdrawal.

Conclusion: The relationship between cryptococcosis and sarcoïdosis has been already described and may be not fortuitous. However it remains a very rare complication of sarcoidosis. Because of its potential severity (mortality rate of 40%), the diagnosis of cryptococcosis should be evoked as a differential diagnosis of neuro-sarcoidosis.

Publication types

  • Case Reports
  • Comparative Study
  • English Abstract

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use
  • Blindness / etiology*
  • Cerebrospinal Fluid Shunts / methods*
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Eye Infections, Fungal / complications*
  • Fluconazole / administration & dosage
  • Fluconazole / therapeutic use
  • Flucytosine / administration & dosage
  • Flucytosine / therapeutic use
  • Fludrocortisone / administration & dosage
  • Fludrocortisone / therapeutic use
  • Follow-Up Studies
  • HIV Seronegativity
  • Humans
  • Hydrocephalus / complications
  • Hydrocephalus / therapy
  • Hydrocortisone / administration & dosage
  • Hydrocortisone / therapeutic use
  • Male
  • Meningitis, Cryptococcal / diagnosis*
  • Meningitis, Cryptococcal / drug therapy
  • Middle Aged
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use
  • Sarcoidosis / cerebrospinal fluid
  • Sarcoidosis / complications*
  • Sarcoidosis / diagnosis
  • Sarcoidosis / drug therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antifungal Agents
  • Amphotericin B
  • Fluconazole
  • Prednisolone
  • Flucytosine
  • Fludrocortisone
  • Hydrocortisone